- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
T
TEVA
Teva Pharm
34.64
+1.20+3.59%After Hours: 34.55 -0.09 -0.26%19:59 07/02 EDT
OPEN/PREV CLOSE35.00/34.64
TODAY RANGE34.58-35.47
VOL4.12M
MARKET CAP41.09B
52 WEEK RANGE14.99-37.35
AVG VOL (3M)6.20M
% TURNOVER0.35%
TURNOVER--
P/E (TTM)26.39
% RANGE2.58%
EPS(TTM)1.338
P/E(FORWARD)55.15
P/B4.992
BVPS7.07
DIVIDEND--
P/S2.351
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP41.09B
SHARES OUTSTANDING1.16B
NEXT EARNINGS07/29-08/04
FREE FLOAT1.16B
LOT SIZE1
EX-DATE11/27/2017
News
Press Releases
Financial Reports
Profile
TipRanks·10h ago
Teva call volume above normal and directionally bullish
The Motley Fool·12h ago
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Simply Wall St·5d ago
How Teva’s Ecopipam NDA for Pediatric Tourette Syndrome (TEVA) Has Changed Its Investment Story
Simply Wall St·6d ago
Teva Pharmaceutical Industries (TEVA) Stock After 99% One Year Surge Is There Value Left
Seeking Alpha·06/28 15:01
Teva Pharmaceutical's Innovative Shift Continues With Ecopipam Addition
TipRanks·06/27 13:00
Lowe’s, Kraft Heinz, Teva, Take-Two, HIVE Insider Shock
NASDAQ·06/26 15:11
SPDW, SPOT, TEVA, SE: ETF Inflow Alert
TipRanks·06/23 02:02
Top Teva Executive Makes a Bold Insider Move With Major Stock Sale
Simply Wall St·06/22 23:32
How Teva’s Ecopipam Tourette NDA and AUSTEDO Data Will Impact Teva Pharmaceutical Industries (TEVA) Investors
NASDAQ·06/22 13:16
Teva Files NDA With FDA For Ecopipam In Pediatric Tourette Syndrome
Simply Wall St·06/21 18:16
Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback
TipRanks·06/19 21:01
3 Best Healthcare Stocks to Buy in June, According to Analysts
Same Industry
Name/Symbol
Change%
Price